Identification of a novel PD-L1 positive solid tumor transplantable in HLA-A*0201/DRB1*0101 transgenic mice-Reference-Cited by-同舟云学术

Identification of a novel PD-L1 positive solid tumor transplantable in HLA-A*0201/DRB1*0101 transgenic mice

Published:2017-04-06 Issue:30 Volume:8 Page:48959-48971
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Rangan Laurie¹²,Galaine Jeanne¹²,Boidot Romain³,Hamieh Mohamad⁴,Dosset Magalie¹²,Francoual Julie⁴,Beziaud Laurent¹²,Pallandre Jean-René¹,Joseph Elodie Lauret Marie¹²,Asgarova Afag¹²,Borg Christophe¹²⁵,Al Saati Talal⁶,Godet Yann¹²,Latouche Jean Baptiste⁷,Valmary-Degano Séverine⁸,Adotévi Olivier¹²⁵

Affiliation:

1. University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-gGreffon-Tumeur, Ingénierie Cellulaire et Génique, F-25000 Besançon, France

2. LabEx LipSTIC, F-25000 Besançon, France

3. Platform for Transfer to Cancer Biology, Centre Georges-François Leclerc, 21000 Dijon, France

4. University Hospital of Rouen, INSERM UMR1245, Institute for Research and Innovation in Biomedicine, 76183 Rouen, France

5. Department of Medical Oncology, University Hospital of Besançon, 25000 Besançon, France

6. INSERM/UPS, US006/CREFRE, Department of Histopathology, University Hospital of Purpan, 31000 Toulouse, France

7. Department of Genetics, University Hospital of Rouen, Normandy Centre for Genomic and Personalized Medicine, 76183 Rouen, France

8. Department of Pathology, University Hospital of Besançon, 25000 Besançon, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Mimicry-Based Strategy Between Human and Commensal Antigens for the Development of a New Family of Immune Therapies for Cancer;2024-06-01

2. Stereotactic Body Radiotherapy and Immunotherapy for Older Patients with Oligometastases: A Proposed Paradigm by the International Geriatric Radiotherapy Group;Cancers;2022-12-30

3. Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients;International Journal of Molecular Sciences;2020-10-02

4. Cancer vaccines: designing artificial synthetic long peptides to improve presentation of class I and class II T cell epitopes by dendritic cells;OncoImmunology;2019-01-17

5. High Therapeutic Efficacy of a New Survivin LSP-Cancer Vaccine Containing CD4+ and CD8+ T-Cell Epitopes;Frontiers in Oncology;2018-11-13